Primary hyperparathyroidism in the older person

被引:19
作者
Conroy, S
Moulias, S
Wassif, WS
机构
[1] Bedford Hosp, Dept Care Elderly, Bedford MK42 9DJ, England
[2] Hop Charles Foix, Med Serv, Ivry, France
[3] Bedford Hosp, Dept Chem Pathol, Bedford MK42 9DJ, England
关键词
hyperparathyroidism/surgery; aetiology; drug therapy; diagnosis; parathyroidectomy; hypercalcaemia/drug therapy; elderly;
D O I
10.1093/ageing/afg122
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Primary hyperparathyroidism (PHPT) is a common condition which may have few symptoms. One of the principal concerns in the older person with minimally symptomatic PHPT is restoration of bone mineral density and prevention of fracture. Other important considerations are cardiovascular risk and quality of fife. Surgery, the traditional treatment of choice, may not always correct these factors. We present a review of the literature and advice of medical therapies which should be of benefit, with emphasis on a multifaceted approach in protecting the patient from PHPT.
引用
收藏
页码:571 / 578
页数:8
相关论文
共 26 条
[11]  
PARFITT A M, 1991, Journal of Bone and Mineral Research, V6, pS97
[12]   Hormonal influences on bone remodeling and bone loss: Application to the management of primary hyperparathyroidism [J].
Parfitt, AM .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (05) :413-415
[13]  
Parfitt AM, 1991, J BONE MINER RES S2, V6
[14]   Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: A 2-year study [J].
Parker, CR ;
Blackwell, PJ ;
Fairbairn, KJ ;
Hosking, DJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4482-4489
[15]   LACK OF BIOCHEMICAL PROGRESSION OR CONTINUATION OF ACCELERATED BONE LOSS IN MILD ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM - EVIDENCE FOR BIPHASIC DISEASE COURSE [J].
RAO, DS ;
WILSON, RJ ;
KLEEREKOPER, M ;
PARFITT, AM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (06) :1294-1298
[16]   Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism [J].
Rossini, M ;
Gatti, D ;
Isaia, G ;
Sartori, L ;
Braga, V ;
Adami, S .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) :113-119
[17]  
SAMPSON MJ, 1987, Q J MED, V65, P1009
[18]   Therapeutic controversies in primary hyperparathyroidism [J].
Silverberg, SJ ;
Bilezikian, JP ;
Bone, HG ;
Talpos, GB ;
Horwitz, MJ ;
Stewart, AF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (07) :2275-2278
[19]   LONGITUDINAL MEASUREMENTS OF BONE-DENSITY AND BIOCHEMICAL INDEXES IN UNTREATED PRIMARY HYPERPARATHYROIDISM [J].
SILVERBERG, SJ ;
GARTENBERG, F ;
JACOBS, TP ;
SHANE, E ;
SIRIS, E ;
STARON, RB ;
BILEZIKIAN, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :723-728
[20]   INCREASED BONE-MINERAL DENSITY AFTER PARATHYROIDECTOMY IN PRIMARY HYPERPARATHYROIDISM [J].
SILVERBERG, SJ ;
GARTENBERG, F ;
JACOBS, TP ;
SHANE, E ;
SIRIS, E ;
STARON, RB ;
MCMAHON, DJ ;
BILEZIKIAN, JP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :729-734